These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Novel Pathogenic Mutations Identified from Whole-Genome Sequencing in Unsolved Cases of Patients Affected with Inherited Retinal Diseases. Hussain HMJ; Wang M; Huang A; Schmidt R; Qian X; Yang P; Marra M; Li Y; Pennesi ME; Chen R Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833373 [TBL] [Abstract][Full Text] [Related]
47. Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results. Cho A; Lima de Carvalho JR; Tanaka AJ; Jauregui R; Levi SR; Bassuk AG; Mahajan VB; Tsang SH Orphanet J Rare Dis; 2020 Jan; 15(1):32. PubMed ID: 32000842 [TBL] [Abstract][Full Text] [Related]
48. Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis. Xiao F; Yan K; Tang M; Ji X; Hu L; Yang L; Zhou W Expert Rev Mol Diagn; 2022 Aug; 22(8):833-840. PubMed ID: 36082848 [TBL] [Abstract][Full Text] [Related]
49. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness. Stark Z; Schofield D; Martyn M; Rynehart L; Shrestha R; Alam K; Lunke S; Tan TY; Gaff CL; White SM Genet Med; 2019 Jan; 21(1):173-180. PubMed ID: 29765138 [TBL] [Abstract][Full Text] [Related]
50. Economic evaluations of whole-genome sequencing for pathogen identification in public health surveillance and health-care-associated infections: a systematic review. Tran M; Smurthwaite KS; Nghiem S; Cribb DM; Zahedi A; Ferdinand AD; Andersson P; Kirk MD; Glass K; Lancsar E; Lancet Microbe; 2023 Nov; 4(11):e953-e962. PubMed ID: 37683688 [TBL] [Abstract][Full Text] [Related]
51. A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium. Mueller S; Jain P; Liang WS; Kilburn L; Kline C; Gupta N; Panditharatna E; Magge SN; Zhang B; Zhu Y; Crawford JR; Banerjee A; Nazemi K; Packer RJ; Petritsch CK; Truffaux N; Roos A; Nasser S; Phillips JJ; Solomon D; Molinaro A; Waanders AJ; Byron SA; Berens ME; Kuhn J; Nazarian J; Prados M; Resnick AC Int J Cancer; 2019 Oct; 145(7):1889-1901. PubMed ID: 30861105 [TBL] [Abstract][Full Text] [Related]
52. Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries. Haider S; Chaikledkaew U; Thavorncharoensap M; Youngkong S; Islam MA; Thakkinstian A Open Forum Infect Dis; 2019 Apr; 6(4):ofz117. PubMed ID: 31049363 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome. Nagashima T; Yamaguchi K; Urakami K; Shimoda Y; Ohnami S; Ohshima K; Tanabe T; Naruoka A; Kamada F; Serizawa M; Hatakeyama K; Ohnami S; Maruyama K; Mochizuki T; Mizuguchi M; Shiomi A; Ohde Y; Bando E; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Kiyohara Y; Tsubosa Y; Katagiri H; Niwakawa M; Takahashi K; Kashiwagi H; Yasunaga Y; Ishida Y; Sugino T; Kenmotsu H; Terashima M; Takahashi M; Uesaka K; Akiyama Y Sci Rep; 2024 Oct; 14(1):23898. PubMed ID: 39396060 [TBL] [Abstract][Full Text] [Related]
54. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies. Chou J; Ohsumi TK; Geha RS Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910 [TBL] [Abstract][Full Text] [Related]
55. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
56. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions. Lavelle TA; Feng X; Keisler M; Cohen JT; Neumann PJ; Prichard D; Schroeder BE; Salyakina D; Espinal PS; Weidner SB; Maron JL Genet Med; 2022 Jun; 24(6):1349-1361. PubMed ID: 35396982 [TBL] [Abstract][Full Text] [Related]
57. Diagnostic Utility of Whole Genome Sequencing After Negative Karyotyping/Chromosomal Microarray in Infants Born With Multiple Congenital Anomalies. Yang M; Kim JA; Jo HS; Park JH; Ahn SY; Sung SI; Park WS; Cho HW; Kim JM; Park MH; Park HY; Jang JH; Chang YS J Korean Med Sci; 2024 Sep; 39(36):e250. PubMed ID: 39315442 [TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods. Ferket BS; Baldwin Z; Murali P; Pai A; Mittendorf KF; Russell HV; Chen F; Lynch FL; Lich KH; Hindorff LA; Savich R; Slavotinek A; Smith HS; Gelb BD; Veenstra DL Genet Med; 2022 Oct; 24(10):2014-2027. PubMed ID: 35833928 [TBL] [Abstract][Full Text] [Related]
59. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency. Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J; J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943 [TBL] [Abstract][Full Text] [Related]
60. Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada? Zawati MH; Parry D; Thorogood A; Nguyen MT; Boycott KM; Rosenblatt D; Knoppers BM J Med Genet; 2014 Jan; 51(1):68-70. PubMed ID: 24078715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]